HomeMAZE • NASDAQ
Maze Therapeutics Inc
add
$13.40
1.11%
After Hours:(0.67%)-0.090
$13.31
Closed: Jun 13, 8:00:00 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 35.40M | 26.37% |
Net income | -32.79M | -0.90% |
Net profit margin | — | — |
Earnings per share | -1.15 | — |
EBITDA | -34.72M | -28.28% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 294.37M | 909.58% |
Total assets | 332.84M | — |
Total liabilities | 40.77M | — |
Total equity | 292.07M | — |
Shares outstanding | 43.80M | — |
Price to book | 2.03 | — |
Return on assets | -30.87% | — |
Return on capital | -32.69% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -32.79M | -0.90% |
Cash from operations | -29.52M | -25.94% |
Cash from investing | -299.00K | -7.17% |
Cash from financing | 127.38M | 418.20% |
Net change in cash | 97.56M | 11,178.96% |
Free cash flow | -21.09M | — |
Previous close
$13.55
Day range
$12.70 - $13.48
Year range
$6.72 - $17.00
Market cap
586.88M USD
Avg Volume
104.42K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2017
Headquarters
Website
Employees
125
